Little bit of action today. I believe it may be hopefuls for the 1/2 yrly coming out over the next couple of weeks, or so.
Whilst I don't give as much immediate chance of improvements as you do this half, (happy with 1.5m EBITDA) it's the forward remarks that have me enthused. As you say, Ambitious, the weakening of the A$ in regards to both the US$ and the CY, bodes well for future profits, and it's the new contracts recently announced that make the 2nd 1/2 look particularly good IMO.
The buy/sell side looks interesting with the new buyers coming on recently. For an Illiquid stock, 1m buys, 200k sells.
If their SPAP catches on in Europe watch out, and as you say, the e-health offers great potential.This for a stock with the MC of $18m. (RMD $9b)
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)